BioLineRx Ltd.

Tel Aviv Stock Exchange:BLRX.TA

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

Israel

Market Cap

USD 14.33 M

Share Price

USD 0.01

Avg Daily Volume

9,508,562

Change (1 day)

-3.89%

Change (1 year)

-85.21%

Change (YTD)

-64.01%

BioLineRx Ltd. EBITDA for the year ending December 31, 2024: USD 3.92 M

BioLineRx Ltd. EBITDA is USD 3.92 M for the year ending December 31, 2024, a -106.86% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

BioLineRx Ltd. EBITDA for the year ending December 31, 2023 was USD -57.09 M, a 100.28% change year over year.
BioLineRx Ltd. EBITDA for the year ending December 31, 2022 was USD -28.50 M, a 18.40% change year over year.
BioLineRx Ltd. EBITDA for the year ending December 31, 2021 was USD -24.07 M, a 7.77% change year over year.
BioLineRx Ltd. EBITDA for the year ending December 31, 2020 was USD -22.34 M, a -16.92% change year over year.